NO20083104L - Fast preparat - Google Patents
Fast preparatInfo
- Publication number
- NO20083104L NO20083104L NO20083104A NO20083104A NO20083104L NO 20083104 L NO20083104 L NO 20083104L NO 20083104 A NO20083104 A NO 20083104A NO 20083104 A NO20083104 A NO 20083104A NO 20083104 L NO20083104 L NO 20083104L
- Authority
- NO
- Norway
- Prior art keywords
- insulin sensitizer
- active ingredient
- solid preparation
- solid composition
- coated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Foreliggende oppfinnelse er tiltenkt å tilveiebringe et fast preparat som inneholder en insulinsensitiserer og en aktiv ingrediens forskjellig fra en insulinsensitiserer, og fremviser oppløsningsoppførsel for en insulinsensitiserer tilsvarende den til en insulinsensitiserer fra "et fast preparat som kun inneholder en insulinsensitiserer som en aktiv ingrediens". Det faste preparatet innbefatter "en del som inneholder belagte partikler hvori partiklene som inneholder en insulinsensitiserer er belagt med laktose eller en sukkeralkohol" og "en del som inneholder en aktiv ingrediens forskjellig fra en insulinsensitiserer".
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005370375 | 2005-12-22 | ||
PCT/JP2006/326169 WO2007072992A2 (en) | 2005-12-22 | 2006-12-21 | Solid preparation containing an insulin sensitizer |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20083104L true NO20083104L (no) | 2008-09-19 |
Family
ID=37951491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20083104A NO20083104L (no) | 2005-12-22 | 2008-07-10 | Fast preparat |
Country Status (24)
Country | Link |
---|---|
US (1) | US8071130B2 (no) |
EP (1) | EP1962811B1 (no) |
JP (1) | JP5179363B2 (no) |
KR (1) | KR20080080126A (no) |
CN (1) | CN101384251B (no) |
AR (1) | AR058605A1 (no) |
AU (1) | AU2006328328B2 (no) |
BR (1) | BRPI0620020A2 (no) |
CA (1) | CA2633149C (no) |
CR (1) | CR10032A (no) |
ES (1) | ES2576258T3 (no) |
GE (1) | GEP20115245B (no) |
HR (1) | HRP20160679T1 (no) |
IL (1) | IL191774A0 (no) |
MA (1) | MA30061B1 (no) |
MY (1) | MY149306A (no) |
NO (1) | NO20083104L (no) |
NZ (1) | NZ569071A (no) |
PE (1) | PE20110019A1 (no) |
RU (1) | RU2426530C2 (no) |
TW (1) | TWI384985B (no) |
UA (1) | UA91729C2 (no) |
WO (1) | WO2007072992A2 (no) |
ZA (1) | ZA200805147B (no) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5162475B2 (ja) | 2006-05-23 | 2013-03-13 | 武田薬品工業株式会社 | ピオグリタゾンを含有する経口剤 |
CL2008000279A1 (es) | 2007-02-01 | 2008-08-18 | Takeda Pharmaceutical | Composicion farmaceutica solida que comprende una parte que comprende 2-((6-(3r)-3-amino-1-piperidinil)3,4-dihidro-3-metil-2,4-dioxo-1-(2h)-pirimidin)metil)benzonitrilo, azucar o alcohol de azucar y una segunda parte que comprende pioglitazona y azuc |
WO2009028487A1 (ja) * | 2007-08-27 | 2009-03-05 | Asahi Kasei Chemicals Corporation | 結晶セルロース及び顆粒含有錠の製造方法 |
EP2413931B1 (en) * | 2009-01-23 | 2016-06-01 | Hanmi Science Co., Ltd. | Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same |
MX337603B (es) * | 2009-11-30 | 2016-03-10 | Adare Pharmaceuticals Inc | Composiciones y tabletas farmaceuticas con recubrimiento compresible y metodos de fabricacion. |
CN101804056A (zh) * | 2010-04-16 | 2010-08-18 | 山东新华制药股份有限公司 | 盐酸吡格列酮、格列美脲的复方片剂及制备方法 |
EP2611434A1 (en) | 2010-09-01 | 2013-07-10 | Lupin Limited | Pharmaceutical composition comprising metformin and pioglitazone |
CA2811634C (en) * | 2010-09-21 | 2019-01-15 | Intekrin Therapeutics, Inc. | Antidiabetic solid pharmaceutical compositions |
FR2966828B1 (fr) * | 2010-11-02 | 2012-12-28 | Roquette Freres | Poudre de polysaccharide et de polyol, comprimable et de haute viscosite |
WO2013034174A1 (en) | 2011-09-06 | 2013-03-14 | ZENTIVA Saglik Ürünleri Sanayi ve Ticaret A.S. | Solid preparations of pioglitazone and glimepiride |
US9592296B2 (en) * | 2011-09-08 | 2017-03-14 | Hexal Ag | Pharmaceutical composition for oral administration with a statin |
WO2013058409A1 (en) | 2011-10-21 | 2013-04-25 | Takeda Pharmaceutical Company Limited | Sustained-release preparation |
US20130158077A1 (en) | 2011-12-19 | 2013-06-20 | Ares Trading S.A. | Pharmaceutical compositions |
US9504679B2 (en) | 2011-12-19 | 2016-11-29 | Bjoern Colin Kahrs | Pharmaceutical compositions comprising glitazones and Nrf2 activators |
CN102641280A (zh) * | 2012-04-23 | 2012-08-22 | 重庆康刻尔制药有限公司 | 一种盐酸吡格列酮格列美脲组合药物、片剂及其应用 |
CA2979033A1 (en) | 2015-03-09 | 2016-09-15 | Intekrin Therapeutics, Inc. | Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy |
US20160331689A1 (en) * | 2015-05-12 | 2016-11-17 | SE Tylose USA, Inc. | Aqueous enteric coating composition |
KR101782119B1 (ko) * | 2016-02-01 | 2017-10-23 | 주식회사 한독 | 테넬리글립틴 및 설포닐우레아계 약물을 포함하는 정제 |
SG11201909046XA (en) | 2017-04-03 | 2019-10-30 | Coherus Biosciences Inc | PPARγ AGONIST FOR TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY |
GB202001237D0 (en) * | 2020-01-29 | 2020-03-11 | Sisteks D O O | Granular pharmaceutical product for oral administration from a pre-filled straw and method of manufacturing such pharmaceutical product |
CN111410687B (zh) * | 2020-02-21 | 2023-06-27 | 成都奥达生物科技有限公司 | 一种长效glp-1化合物 |
CN115721612A (zh) * | 2021-08-26 | 2023-03-03 | 上海宣泰医药科技股份有限公司 | 一种恩扎卢胺固体制剂颗粒及其制备方法 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3152978B2 (ja) | 1991-12-17 | 2001-04-03 | 塩野義製薬株式会社 | 二層錠およびその製造方法 |
TW438587B (en) | 1995-06-20 | 2001-06-07 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
US5859037A (en) | 1997-02-19 | 1999-01-12 | Warner-Lambert Company | Sulfonylurea-glitazone combinations for diabetes |
ATE353654T1 (de) | 1997-06-18 | 2007-03-15 | Smithkline Beecham Plc | Behandlung der diabetes mit thiazolidindione und sulphonylurea |
GB9715306D0 (en) | 1997-07-18 | 1997-09-24 | Smithkline Beecham Plc | Novel method of treatment |
ES2347968T3 (es) | 1998-07-28 | 2010-11-26 | Takeda Pharmaceutical Company Limited | Preparacion solida que se disgrega rapidamente. |
JP2002529504A (ja) * | 1998-11-12 | 2002-09-10 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | インスリン感作物質および他の抗糖尿病薬の放出修飾のための医薬組成物 |
ES2244416T5 (es) | 1999-01-14 | 2020-01-03 | Amylin Pharmaceuticals Llc | Formulaciones novedosas de agonistas de la exendina y métodos de administración de los mismos |
US6294192B1 (en) | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
US6383471B1 (en) | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
AR030920A1 (es) | 1999-11-16 | 2003-09-03 | Smithkline Beecham Plc | Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones |
US7510728B2 (en) * | 2000-10-06 | 2009-03-31 | Takeda Pharmaceutical Company Limited | Solid preparations |
JP4284017B2 (ja) * | 2000-10-06 | 2009-06-24 | 武田薬品工業株式会社 | 固形製剤 |
RU2177318C1 (ru) | 2000-12-21 | 2001-12-27 | Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" | Фармацевтическая композиция с антидиабетическим действием и способ ее получения |
US20040147584A2 (en) * | 2001-12-05 | 2004-07-29 | Aventis Pharma S.A. | 1,3-diarylprop-2-en-1-ones, compositions containing them and use thereof |
US6682759B2 (en) | 2002-02-01 | 2004-01-27 | Depomed, Inc. | Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs |
CA2492722A1 (en) | 2002-07-11 | 2004-01-22 | Takeda Pharmaceutical Company Limited | Production method of coated preparations |
IL161559A0 (en) | 2002-08-30 | 2004-09-27 | Japan Tobacco Inc | Dibenzylamine derivatives and pharmaceutical compositions containing the same |
UA80991C2 (en) | 2002-10-07 | 2007-11-26 | Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes | |
US20040147564A1 (en) | 2003-01-29 | 2004-07-29 | Rao Vinay U. | Combinations of glimepiride and the thiazolidinedione for treatment of diabetes |
MXPA05007883A (es) | 2003-01-29 | 2005-09-21 | Takeda Pharmaceutical | Proceso para producir una preparacion recubierta. |
WO2004069229A1 (en) * | 2003-02-05 | 2004-08-19 | Ipca Laboratories Limited | Dual release anti-diabetic drugs and process of production thereof |
WO2004091587A1 (en) * | 2003-04-17 | 2004-10-28 | Ipca Laboratories Limited | Multiple release anti-diabetic drugs and process of production thereof |
WO2004108161A1 (ja) | 2003-06-06 | 2004-12-16 | Takeda Pharmaceutical Company Limited | 固形製剤 |
BRPI0412009A (pt) | 2003-06-27 | 2006-08-15 | Reddy Research Foundation | composições compreendendo balaglitazona e outros compostos antidiabéticos |
WO2005009407A2 (en) * | 2003-07-29 | 2005-02-03 | Ranbaxy Laboratories Limited | Oral pharmaceutical formulations of olanzapine |
JP4361461B2 (ja) * | 2003-10-31 | 2009-11-11 | 武田薬品工業株式会社 | 固形製剤 |
US7700128B2 (en) * | 2003-10-31 | 2010-04-20 | Takeda Pharmaceutical Company Limited | Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester |
JP4739189B2 (ja) | 2004-04-14 | 2011-08-03 | 武田薬品工業株式会社 | 固形製剤 |
WO2005102290A1 (en) * | 2004-04-22 | 2005-11-03 | Ranbaxy Laboratories Limited | Pharmaceutical compositions of a biguanide and a sulfonylurea |
-
2006
- 2006-12-21 EP EP06843549.4A patent/EP1962811B1/en active Active
- 2006-12-21 CA CA2633149A patent/CA2633149C/en active Active
- 2006-12-21 ZA ZA200805147A patent/ZA200805147B/xx unknown
- 2006-12-21 AR ARP060105709A patent/AR058605A1/es not_active Application Discontinuation
- 2006-12-21 WO PCT/JP2006/326169 patent/WO2007072992A2/en active Application Filing
- 2006-12-21 KR KR1020087014632A patent/KR20080080126A/ko active IP Right Grant
- 2006-12-21 RU RU2008130074/15A patent/RU2426530C2/ru not_active IP Right Cessation
- 2006-12-21 US US12/086,700 patent/US8071130B2/en active Active
- 2006-12-21 ES ES06843549.4T patent/ES2576258T3/es active Active
- 2006-12-21 GE GEAP200610776A patent/GEP20115245B/en unknown
- 2006-12-21 TW TW095148113A patent/TWI384985B/zh not_active IP Right Cessation
- 2006-12-21 CN CN200680053318.XA patent/CN101384251B/zh active Active
- 2006-12-21 BR BRPI0620020-6A patent/BRPI0620020A2/pt not_active IP Right Cessation
- 2006-12-21 PE PE2010001114A patent/PE20110019A1/es not_active Application Discontinuation
- 2006-12-21 MY MYPI20082251A patent/MY149306A/en unknown
- 2006-12-21 NZ NZ569071A patent/NZ569071A/en not_active IP Right Cessation
- 2006-12-21 AU AU2006328328A patent/AU2006328328B2/en not_active Ceased
- 2006-12-21 UA UAA200808310A patent/UA91729C2/ru unknown
- 2006-12-21 JP JP2008528691A patent/JP5179363B2/ja active Active
-
2008
- 2008-05-27 IL IL191774A patent/IL191774A0/en unknown
- 2008-05-30 CR CR10032A patent/CR10032A/es not_active Application Discontinuation
- 2008-06-18 MA MA31045A patent/MA30061B1/fr unknown
- 2008-07-10 NO NO20083104A patent/NO20083104L/no not_active Application Discontinuation
-
2016
- 2016-06-14 HR HRP20160679TT patent/HRP20160679T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0620020A2 (pt) | 2011-10-25 |
CA2633149A1 (en) | 2007-06-28 |
RU2426530C2 (ru) | 2011-08-20 |
MA30061B1 (fr) | 2008-12-01 |
ZA200805147B (en) | 2010-05-26 |
TWI384985B (zh) | 2013-02-11 |
US20090028939A1 (en) | 2009-01-29 |
RU2008130074A (ru) | 2010-01-27 |
GEP20115245B (en) | 2011-06-27 |
CR10032A (es) | 2008-10-03 |
TW200731971A (en) | 2007-09-01 |
KR20080080126A (ko) | 2008-09-02 |
MY149306A (en) | 2013-08-30 |
AU2006328328A1 (en) | 2007-06-28 |
EP1962811A2 (en) | 2008-09-03 |
AR058605A1 (es) | 2008-02-13 |
CA2633149C (en) | 2015-06-30 |
PE20110019A1 (es) | 2011-01-27 |
ES2576258T3 (es) | 2016-07-06 |
JP2009520681A (ja) | 2009-05-28 |
AU2006328328B2 (en) | 2012-08-30 |
JP5179363B2 (ja) | 2013-04-10 |
HRP20160679T1 (hr) | 2016-07-15 |
US8071130B2 (en) | 2011-12-06 |
EP1962811B1 (en) | 2016-04-27 |
IL191774A0 (en) | 2008-12-29 |
NZ569071A (en) | 2011-01-28 |
WO2007072992A3 (en) | 2007-12-06 |
CN101384251B (zh) | 2014-09-03 |
CN101384251A (zh) | 2009-03-11 |
WO2007072992A2 (en) | 2007-06-28 |
UA91729C2 (ru) | 2010-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20083104L (no) | Fast preparat | |
BRPI0518553A2 (pt) | composiÇço farmacÊutica estÁvel, mÉtodo para estabilizaÇço de pelo menos um ingrediente farmaceuticamente ativo e mÉtodo de uso de celulose microcristalina silicificada | |
NO20065442L (no) | Amidoforbindelser og deres anvendelse som legemidler | |
NO20071048L (no) | Amidoforbindelser og deres anvendelse som farmasoytika | |
SG171649A1 (en) | Dpp iv inhibitor formulations | |
CR20110110A (es) | Composicion farmaceutica | |
RS51304B (sr) | Farmaceutske kompozicije neuroaktivnog steroida i njihova upotreba | |
NO20064584L (no) | Tetrahydropyridoindolderivater | |
WO2007103719A3 (en) | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | |
EA200870216A1 (ru) | Амидо соединения и их применение в качестве лекарственных средств | |
NO20070372L (no) | Amidoforbindelser og anvendelse derav som farmasoytiske preparater | |
NO20082047L (no) | Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme | |
WO2007084314A3 (en) | MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | |
EA200800783A1 (ru) | Композиция тразодона для введения один раз в день | |
BRPI0710508B8 (pt) | composição de pepticorpo terapêutico liofilizado estável, kit para preparar uma composição farmacêutica aquosa, e métodos para fabricar um pepticorpo terapêutico liofilizado e para preparar uma composição de pepticorpo terapêutico reconstituído | |
MY160703A (en) | Crystalline forms of (r) -5- [3-chloro-4-(2,3-dihydroxy) - benz [z] ylidene] -2- ([z]-propylimino) -3-0-tolyl-thiazolidin-4-one | |
NO20083027L (no) | Kontrollert frigivelses-fastformpreparat | |
NO20090141L (no) | Stabiliserte, farmasøytiske preparater som omfatter fesoterodin | |
NO20073059L (no) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists | |
NO20090407L (no) | Aerosolformulering for inhalering av beta agonister | |
EA200970532A1 (ru) | Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола | |
NO20074933L (no) | Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat | |
BR112013030939A2 (pt) | derivado de indazol e pirrolopiridina e uso farmacêutico do mesmo | |
EA201170512A1 (ru) | Композиция для перорального введения | |
CL2007000789A1 (es) | Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |